LCFA Awards

Awarded Grants

Since its establishment in 2007, LCFA has funded nearly $600,000 in lung cancer research grants in partnership with the largest international clinical society focusing on lung cancer, the IASLC (International Association for the Study of Lung Cancer).

DR. DANIEL COSTA, M.D.

DR. DANIEL COSTA of Beth Israel Deaconess Medical Center (a teaching hospital of Harvard Medical School) received the 2012 LCFA/IASLC Grant in Translational Lung Cancer Research. Dr. Costa has received the $300,000.00 two-year grant, to study Non-Small Cell Lung Cancer (NSCLC) patients with different EGFR mutations. Dr. Costa and his team are evaluating these selected patients for sensitivity and resistance to EGFR tyrosine kinase inhibitors (TKIs) to determine a genotype-response correlation.

Dr. Costa, a native of Brazil, received his MD from University of Sao Paulo’s Faculdade de…
Read More

DR. JESSICA DONINGTON, M.D.

DR. JESSICA DONINGTON was selected from more than a dozen international applicants to receive one of LCFA’s first scientific research grants. In partnership with the International Association for the Study of Lung Cancer (IASLC), the LCFA Lung Cancer Research Grant awarded a 2-year $250,000 grant to Dr. Donington at New York University (NYU) for her research.

Dr .Donington, a native New Yorker trained at…
Read More

Dr. Goeffrey Liu

DR. GOEFFREY LIU was also selected from more than a dozen international applicants to receive the second of LCFA’s initial scientific research grants. In partnership with the International Association for the Study of Lung Cancer (IASLC), the LCFA Lung Cancer Research Grant awarded $39,000 to Dr. Goeffrey Liu for his study of the genetic differences in patients treated with anti-angiogenic agents. Dr Liu’s research endeavored to see if he could identify which patients benefit…
Read More